Adrián Chrastina
- Molecular Biology
- Biomaterials top 5%
- Biomedical Engineering
- Cancer Research top 10%
- Cell Biology top 10%
- Co-authors
- Jan E. SchnitzerKerri A. MasseyPer BorgströmSilvia PastorekováPhil OhJacqueline E. TestaMilota KaluzováJaromı́r Pastorek
- Topics
- Bioactive Compounds and Antitumor Agents (5 papers)Enzyme function and inhibition (4 papers)Cell Adhesion Molecules Research (4 papers)
- Partner nations
- United StatesSlovakiaBelgium
In The Last Decade
Adrián Chrastina
22 papers receiving 881 citations
Peers
Comparison fields: 5 of 102
- Molecular Biology 510
- Biomaterials 206
- Biomedical Engineering 180
- Cancer Research 161
- Cell Biology 120
Countries citing papers authored by Adrián Chrastina
This map shows the geographic impact of Adrián Chrastina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adrián Chrastina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adrián Chrastina more than expected).
Fields of papers citing papers by Adrián Chrastina
This network shows the impact of papers produced by Adrián Chrastina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adrián Chrastina. The network helps show where Adrián Chrastina may publish in the future.
Co-authorship network of co-authors of Adrián Chrastina
This figure shows the co-authorship network connecting the top 25 collaborators of Adrián Chrastina. A scholar is included among the top collaborators of Adrián Chrastina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adrián Chrastina. Adrián Chrastina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 13 | |
| 2 | 7 | |
| 3 | 8 | |
| 4 | 8 | |
| 5 | 19 | |
| 6 | 29 | |
| 7 | 12 | |
| 8 | 16 | |
| 9 | 2 | |
| 10 | 147 | |
| 11 | 41 | |
| 12 | 21 | |
| 13 | 13 | |
| 14 | 20 | |
| 15 | 242 | |
| 16 | 23 | |
| 17 | 81 | |
| 18 | Immunotargeting of human cervical carcinoma xenograft expressing CA IX tumor-associated antigen by 125I-labeled M75 monoclonal antibody. | 22 |
| 19 | Lowered oxygen tension induces expression of the hypoxia marker MN/carbonic anhydrase IX in the absence of hypoxia-inducible factor 1 alpha stabilization: a role for phosphatidylinositol 3'-kinase. | 126 |
| 20 | 7 |
About Adrián Chrastina
Adrián Chrastina is a scholar working on Toxicology, Immunology and Allergy and Cell Biology, having authored 22 papers that have together received 908 indexed citations. Recurring topics across this work include Bioactive Compounds and Antitumor Agents (5 papers), Enzyme function and inhibition (4 papers) and Cell Adhesion Molecules Research (4 papers). The work is most often cited by research in Toxicology (67 citations), Biomaterials (206 citations) and Cancer Research (161 citations). Adrián Chrastina has collaborated with scholars based in United States, Slovakia and Belgium. Frequent co-authors include Jan E. Schnitzer, Kerri A. Massey, Per Borgström, Silvia Pastoreková, Phil Oh, Jacqueline E. Testa, Milota Kaluzová, Jaromı́r Pastorek, Štefan Kaluz and Halina Witkiewicz. Their work appears in journals such as Journal of Biological Chemistry, Nature Biotechnology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.